Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2021, titled "Alembic Pharmaceuticals announces its joint venture, Aleor Dermaceuticals Limited, receives USFDA Final Approval for Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1 mg/gram".